Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,615 | 644 | 80.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,250 | 1 | 18.8% |
| Education | $124.30 | 3 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,535 | 67 | $0 (2024) |
| Novo Nordisk Inc | $1,445 | 118 | $0 (2024) |
| Lilly USA, LLC | $959.54 | 82 | $0 (2024) |
| Amgen Inc. | $780.04 | 57 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $744.56 | 25 | $0 (2024) |
| PFIZER INC. | $560.18 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $557.73 | 51 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $335.33 | 21 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $303.47 | 22 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $224.74 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,893 | 104 | ABBVIE INC. ($456.54) |
| 2023 | $1,808 | 125 | AbbVie Inc. ($403.42) |
| 2022 | $3,698 | 89 | ABBVIE INC. ($2,593) |
| 2021 | $1,122 | 79 | Novo Nordisk Inc ($256.78) |
| 2020 | $664.64 | 47 | Novo Nordisk Inc ($134.80) |
| 2019 | $1,036 | 69 | Novo Nordisk Inc ($280.79) |
| 2018 | $1,088 | 75 | AstraZeneca Pharmaceuticals LP ($263.85) |
| 2017 | $680.53 | 60 | Lilly USA, LLC ($135.89) |
All Payment Transactions
648 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: RETT SYNDROME | ||||||
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $113.94 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: VACCINES | ||||||
| 12/09/2024 | Organon Llc | — | Food and Beverage | In-kind items and services | $22.01 | General |
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Diabetes Care | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.61 | General |
| 11/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: VACCINES | ||||||
| 10/25/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: Bone Health | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.90 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: PAIN | ||||||
| 10/02/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: General - Pain Management_NMD | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Cardio-renal | ||||||
| 09/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.42 | General |
| Category: PSYCHIATRY | ||||||
| 09/23/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: ETONOGESTREL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,653 | 3,414 | $485,177 | $141,789 |
| 2022 | 18 | 1,654 | 2,212 | $260,961 | $104,132 |
| 2021 | 19 | 1,681 | 2,193 | $255,573 | $99,065 |
| 2020 | 14 | 1,286 | 1,639 | $189,236 | $64,240 |
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 95 | 95 | $3,325 | $1,505 | 45.3% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 12 | 12 | $3,084 | $1,499 | 48.6% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 20 | 20 | $980.00 | $745.00 | 76.0% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 25 | 26 | $1,716 | $514.62 | 30.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 34 | 36 | $1,728 | $361.68 | 20.9% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 40 | 41 | $574.00 | $255.43 | 44.5% |
| 74018 | X-ray of abdomen, 1 view | Office | 2021 | 12 | 13 | $767.00 | $252.72 | 32.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 15 | 15 | $525.00 | $237.42 | 45.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 40 | 41 | $533.00 | $212.38 | 39.8% |
| 72100 | X-ray of lower and sacral spine, 2 or 3 views | Office | 2021 | 12 | 12 | $924.00 | $196.77 | 21.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 30 | 43 | $258.00 | $96.75 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 187 | 187 | $46,376 | $20,411 | 44.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 208 | 312 | $72,384 | $19,970 | 27.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 229 | 255 | $40,704 | $10,510 | 25.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 73 | 73 | $8,760 | $4,452 | 50.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 14 | 14 | $5,138 | $2,260 | 44.0% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 18 | 18 | $4,626 | $2,143 | 46.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 291 | 497 | $3,479 | $1,482 | 42.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 81 | 81 | $2,835 | $1,276 | 45.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 28 | 28 | $980.00 | $440.36 | 44.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 28 | 30 | $1,440 | $341.36 | 23.7% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 15 | 15 | $990.00 | $329.08 | 33.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2020 | 47 | 50 | $700.00 | $305.84 | 43.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2020 | 47 | 50 | $650.00 | $254.47 | 39.1% |
| 81003 | Automated urinalysis test | Office | 2020 | 20 | 29 | $174.00 | $64.80 | 37.2% |
About Dr. Christopher Connolly, M.D
Dr. Christopher Connolly, M.D is a Family Medicine healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881616167.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Connolly, M.D has received a total of $11,989 in payments from pharmaceutical and medical device companies, with $1,893 received in 2024. These payments were reported across 648 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($9,615).
As a Medicare-enrolled provider, Connolly has provided services to 6,274 Medicare beneficiaries, totaling 9,458 services with total Medicare billing of $409,226. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Omaha, NE
- Active Since 07/24/2006
- Last Updated 12/09/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1881616167
Products in Payments
- UBRELVY (Drug) $2,789
- Ozempic (Drug) $605.53
- QULIPTA (Drug) $472.29
- EVENITY (Biological) $375.29
- VRAYLAR (Drug) $354.16
- Kerendia (Drug) $303.47
- FARXIGA (Drug) $285.17
- Saxenda (Drug) $283.41
- NURTEC ODT (Drug) $246.77
- MOUNJARO (Drug) $241.60
- Prolastin-C Liquid (Biological) $223.66
- TRULICITY (Drug) $218.07
- TRELEGY ELLIPTA (Drug) $209.41
- EMGALITY (Drug) $191.40
- Vascepa (Drug) $188.17
- Prolia (Biological) $181.94
- PREVNAR 20 (Biological) $177.49
- Victoza (Drug) $177.39
- SYMBICORT (Drug) $172.62
- INVEGA SUSTENNA (Drug) $167.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Omaha
Dr. Gerard Stanley, M.d, M.D
Family Medicine — Payments: $49,779
M. Dada, M.d., Ph.d, M.D., PH.D
Family Medicine — Payments: $14,443
Dr. Yongge Liu, M.d, M.D
Family Medicine — Payments: $13,977
Christopher Beasley, Pa-C, PA-C
Family Medicine — Payments: $11,635
Joseph Dumba, M.d, M.D
Family Medicine — Payments: $10,949
Dr. Ferdinando Andrade, M.d, M.D
Family Medicine — Payments: $10,854